sirtris registers for an ipo cambridge mass sirtris pharmaceuticals inc a biotechnology start up aiming to commercialize a red wine ingredient that has been linked to anti aging effects filed papers to go public in a filing with the securities and exchange commission sirtris says it will sell up to &# million in stock but provided no estimate of a price range the company said it will use the proceeds to continue development of its formulation of resveratrol a substance found in red wine sirtris is currently testing the drug as a treatment for diabetes sirtris said it has had a cumulative deficit of &# million and generated no revenue last year 
